Pfizer has been among the top stocks during this year's market correction. Recently it has been trading within a 1D Channel Up which just priced its Higher Low (RSI = 48.610, MACD = 0.230, highs/Lows = 0.0000). Assuming it will print an identical Higher High next on +3.60%, we have a long target of $48.00 by mid January. Note that Pfizer also packs a decent quarterly dividend (yields 3.1%).
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.